Astrazeneca’s revenue surges as pipeline investments pay off April 25, 2024 Pascal Soriot, chief executive officer of AstraZeneca, said: "Astrazeneca had a very strong start in 2024 with substantial total revenue growth of 19 per cent in the first quarter.
Angle agrees deal with Astrazeneca for tech to kill cancer cells April 24, 2024 This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment.
How much is too much? The CEO pay predicament April 23, 2024 A growing number of London-listed companies have been asking shareholders to approve radical pay rises for their top execs. Why?
Flush FTSE 100 giant Astrazeneca to give more back to shareholders with dividend hike April 11, 2024 AstraZeneca will increase its annual dividend for the year by $0.20 (16p) to $3.10 (£2.47) per share
Covid-19 anniversary: How have GSK and Astrazeneca fared since? March 23, 2024 The Covid-19 pandemic also ignited interest in the pharmaceutical sector. Even before the UK went into lockdown, the sector was looking for ways to fight the virus.
Astrazeneca expands cancer treatment stable with purchase of Canada-based Fusion March 19, 2024 The Cambridge-based pharma firm is paying $2bn cash up front as part of the deal
Spring Budget 2024: Astrazeneca to invest £650m in Cambridge and Liverpool March 6, 2024 AstraZeneca is to invest £650m in the UK, Chancellor Jeremy Hunt has announced in his Spring Budget.
Astrazeneca share price rises as Tagrisso drug shows ‘highly impactful’ results in lung cancer trial February 19, 2024 Results from Tagrisso's Phase III trial showed a "statistically significant and highly clinically meaningful improvement" in progression-free survival.
FTSE 100 close: London dragged lower by Astrazeneca, DS Smith soars after takeover rumours February 8, 2024 Shares in Astrazeneca, the biggest company listed in London, dropped 6.3 per cent even after reporting an increase in revenue in 2023.
Astrazeneca shares plummet despite FTSE 100’s biggest firm posting revenue boost February 8, 2024 Astrazeneca said excluding coronavirus, its total sales increased by 15 per cent, as its chief executive predicted "double digit earnings" for the year ahead.